Chemotherapy
a. ABVD regimen (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) is commonly used.
b. BEACOPP regimen may be considered for advanced stages.

Radiation Therapy
a. Used post-chemotherapy for localized disease.
b. Helps in reducing recurrence risk.

Targeted Therapy and Immunotherapy
a. Brentuximab vedotin for relapsed cases.
b. Checkpoint inhibitors like nivolumab for refractory Hodgkin lymphoma.

Stem Cell Transplant
a. Autologous stem cell transplant is considered after relapse or if initial treatment fails.

Supportive Care and Monitoring
a. Regular follow-ups for monitoring.
b. Manage side effects and maintain quality of life.